TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data. September 26, 2008